| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 7 | 2014 | 242 | 1.030 |
Why?
|
| Liver Regeneration | 5 | 2013 | 40 | 0.980 |
Why?
|
| Arginine | 2 | 2025 | 349 | 0.980 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2025 | 93 | 0.940 |
Why?
|
| Hepatectomy | 5 | 2014 | 124 | 0.880 |
Why?
|
| Cytokines | 3 | 2025 | 1396 | 0.770 |
Why?
|
| Receptors, Purinergic P2Y2 | 3 | 2023 | 16 | 0.730 |
Why?
|
| Macrophages | 1 | 2025 | 704 | 0.700 |
Why?
|
| Bacterial Infections | 1 | 2023 | 325 | 0.680 |
Why?
|
| Bacteremia | 1 | 2023 | 418 | 0.630 |
Why?
|
| Sepsis | 1 | 2023 | 516 | 0.600 |
Why?
|
| Adenosine Triphosphate | 5 | 2015 | 295 | 0.530 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2015 | 3 | 0.500 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2014 | 4 | 0.460 |
Why?
|
| Lipopolysaccharides | 4 | 2025 | 320 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 4821 | 0.410 |
Why?
|
| Liver | 7 | 2023 | 1875 | 0.350 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 202 | 0.350 |
Why?
|
| Nanoparticles | 2 | 2012 | 285 | 0.310 |
Why?
|
| Animals | 35 | 2025 | 36398 | 0.310 |
Why?
|
| Polynucleotides | 1 | 2008 | 9 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 213 | 0.300 |
Why?
|
| Cell Cycle | 4 | 2015 | 627 | 0.300 |
Why?
|
| Ileum | 5 | 2021 | 136 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2122 | 0.280 |
Why?
|
| Adipose Tissue | 1 | 2010 | 507 | 0.280 |
Why?
|
| Mice | 15 | 2025 | 18911 | 0.270 |
Why?
|
| Mice, Knockout | 8 | 2023 | 3980 | 0.270 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 999 | 0.260 |
Why?
|
| Acetaldehyde | 3 | 1994 | 8 | 0.250 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 1410 | 0.240 |
Why?
|
| Argininosuccinate Synthase | 1 | 2025 | 25 | 0.240 |
Why?
|
| RAW 264.7 Cells | 1 | 2025 | 45 | 0.240 |
Why?
|
| Argininosuccinate Lyase | 1 | 2025 | 65 | 0.230 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2001 | 11 | 0.230 |
Why?
|
| Lung | 4 | 2014 | 1557 | 0.230 |
Why?
|
| Carrier Proteins | 7 | 2002 | 1066 | 0.220 |
Why?
|
| Cells, Cultured | 6 | 2018 | 3167 | 0.220 |
Why?
|
| Signal Transduction | 8 | 2018 | 4900 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 324 | 0.220 |
Why?
|
| Mitogens | 1 | 2004 | 32 | 0.220 |
Why?
|
| Citrulline | 1 | 2025 | 114 | 0.220 |
Why?
|
| Receptors, Purinergic | 1 | 2023 | 15 | 0.220 |
Why?
|
| Retinoid X Receptor alpha | 3 | 2009 | 20 | 0.210 |
Why?
|
| Nucleotides | 1 | 2023 | 94 | 0.210 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2014 | 39 | 0.200 |
Why?
|
| Gene Deletion | 2 | 2023 | 809 | 0.200 |
Why?
|
| Nitric Oxide | 1 | 2025 | 490 | 0.190 |
Why?
|
| Neurites | 1 | 2001 | 46 | 0.180 |
Why?
|
| Bile Acids and Salts | 5 | 2010 | 259 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 1999 | 56 | 0.180 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2021 | 45 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2021 | 41 | 0.170 |
Why?
|
| Amino Acids | 1 | 2023 | 688 | 0.170 |
Why?
|
| Enterocytes | 1 | 2021 | 75 | 0.170 |
Why?
|
| Rats | 14 | 2009 | 3885 | 0.170 |
Why?
|
| Kidney | 6 | 2012 | 1410 | 0.160 |
Why?
|
| Myocardium | 2 | 2018 | 1046 | 0.160 |
Why?
|
| Liposomes | 2 | 2012 | 207 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2015 | 2539 | 0.150 |
Why?
|
| Cholic Acids | 1 | 2018 | 16 | 0.150 |
Why?
|
| Cell Differentiation | 3 | 2021 | 2026 | 0.150 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 103 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 2 | 2011 | 111 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 315 | 0.140 |
Why?
|
| Ankyrins | 1 | 1998 | 95 | 0.140 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2006 | 94 | 0.140 |
Why?
|
| Cardiotonic Agents | 1 | 2018 | 144 | 0.140 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 271 | 0.130 |
Why?
|
| Cell Division | 2 | 2011 | 774 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2015 | 1134 | 0.130 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 12 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 1996 | 226 | 0.120 |
Why?
|
| Cholic Acid | 2 | 2014 | 20 | 0.120 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 4 | 2002 | 28 | 0.120 |
Why?
|
| Symporters | 4 | 2002 | 75 | 0.110 |
Why?
|
| Cyclins | 1 | 2014 | 104 | 0.110 |
Why?
|
| Blood Proteins | 1 | 1994 | 136 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 77 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 1994 | 103 | 0.110 |
Why?
|
| Interleukin-1 | 2 | 2006 | 146 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1761 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 971 | 0.100 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2014 | 87 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 142 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2004 | 260 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 90 | 0.100 |
Why?
|
| Cholestasis | 2 | 2014 | 158 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1326 | 0.100 |
Why?
|
| Homeostasis | 2 | 2015 | 749 | 0.100 |
Why?
|
| Brain | 2 | 2001 | 3220 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 247 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 166 | 0.100 |
Why?
|
| Male | 15 | 2021 | 65882 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2012 | 119 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 381 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2015 | 388 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 141 | 0.090 |
Why?
|
| Glucose | 1 | 2015 | 924 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 400 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2010 | 17 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 351 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Transfection | 6 | 2006 | 1089 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2001 | 607 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2009 | 1310 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 514 | 0.080 |
Why?
|
| Purinergic P2 Receptor Antagonists | 2 | 2009 | 5 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1315 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 168 | 0.080 |
Why?
|
| Gene Expression | 3 | 2010 | 1614 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 508 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2009 | 17 | 0.080 |
Why?
|
| Mineral Oil | 1 | 2008 | 4 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2010 | 213 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 158 | 0.080 |
Why?
|
| Viscosity | 1 | 2008 | 43 | 0.070 |
Why?
|
| Emulsions | 1 | 2008 | 71 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2008 | 38 | 0.070 |
Why?
|
| Cell Line | 6 | 2012 | 2837 | 0.070 |
Why?
|
| Particle Size | 1 | 2008 | 148 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3751 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 383 | 0.070 |
Why?
|
| Rabbits | 3 | 2012 | 736 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 1127 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2008 | 96 | 0.070 |
Why?
|
| Hepatitis, Animal | 1 | 2006 | 1 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2008 | 170 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 85 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 5173 | 0.060 |
Why?
|
| Base Sequence | 5 | 2006 | 3171 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2002 | 98 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1607 | 0.060 |
Why?
|
| Dogs | 4 | 1999 | 800 | 0.060 |
Why?
|
| Heart | 1 | 2010 | 749 | 0.060 |
Why?
|
| Cattle | 2 | 1999 | 588 | 0.060 |
Why?
|
| Radioligand Assay | 2 | 2001 | 27 | 0.060 |
Why?
|
| Heart Failure | 1 | 2018 | 2417 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2009 | 1702 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2004 | 89 | 0.050 |
Why?
|
| Molecular Weight | 3 | 1999 | 388 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 59 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2004 | 123 | 0.050 |
Why?
|
| Molecular Sequence Data | 5 | 1998 | 3970 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 1999 | 71 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2001 | 26 | 0.050 |
Why?
|
| Growth Cones | 1 | 2001 | 16 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2001 | 23 | 0.050 |
Why?
|
| COS Cells | 2 | 2000 | 283 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2014 | 1045 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1998 | 2785 | 0.050 |
Why?
|
| Feedback | 1 | 2002 | 166 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 9887 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2001 | 56 | 0.040 |
Why?
|
| RNA, Messenger | 6 | 2009 | 2903 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 185 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2000 | 432 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2001 | 176 | 0.040 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2000 | 17 | 0.040 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2000 | 7 | 0.040 |
Why?
|
| Ouabain | 1 | 2000 | 29 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 2000 | 48 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 783 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4776 | 0.040 |
Why?
|
| Longevity | 1 | 2021 | 158 | 0.040 |
Why?
|
| Enzymes, Immobilized | 1 | 1999 | 7 | 0.040 |
Why?
|
| Lisinopril | 1 | 1999 | 23 | 0.040 |
Why?
|
| fas Receptor | 1 | 1999 | 50 | 0.040 |
Why?
|
| Female | 6 | 2021 | 71659 | 0.040 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1998 | 8 | 0.040 |
Why?
|
| Kidney Medulla | 1 | 1998 | 19 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2018 | 39 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 589 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1999 | 317 | 0.040 |
Why?
|
| Caspases | 1 | 1999 | 167 | 0.040 |
Why?
|
| Humans | 13 | 2015 | 133932 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1418 | 0.040 |
Why?
|
| Aged | 2 | 2015 | 21730 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 87 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1998 | 298 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 1631 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2000 | 941 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 20536 | 0.030 |
Why?
|
| Stem Cells | 1 | 2002 | 753 | 0.030 |
Why?
|
| Colon | 1 | 2000 | 379 | 0.030 |
Why?
|
| Cholesterol | 1 | 2000 | 574 | 0.030 |
Why?
|
| Kinetics | 1 | 1999 | 1355 | 0.030 |
Why?
|
| Adult | 2 | 2015 | 31946 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 292 | 0.030 |
Why?
|
| Ethanol | 2 | 1994 | 171 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2006 | 132 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 6588 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 619 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 801 | 0.030 |
Why?
|
| Middle Aged | 1 | 2015 | 29394 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2002 | 2704 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 1994 | 25 | 0.030 |
Why?
|
| Trypsin | 1 | 1994 | 95 | 0.030 |
Why?
|
| Renin | 1 | 1994 | 88 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1994 | 14 | 0.030 |
Why?
|
| Biliary Atresia | 1 | 1997 | 204 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1994 | 85 | 0.030 |
Why?
|
| Perilipin-2 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 179 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 1998 | 104 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2014 | 94 | 0.030 |
Why?
|
| Lipoproteins, VLDL | 1 | 2013 | 57 | 0.030 |
Why?
|
| Nephrectomy | 1 | 1994 | 181 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1757 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 815 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2013 | 59 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 264 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 197 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1994 | 1735 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 197 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 22 | 0.020 |
Why?
|
| Retinoid X Receptors | 2 | 2002 | 32 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 2656 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 465 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 327 | 0.020 |
Why?
|
| Apoptosis | 1 | 1999 | 1931 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 718 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2014 | 474 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2002 | 35 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1998 | 1621 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 252 | 0.020 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2010 | 3 | 0.020 |
Why?
|
| Glycogen | 1 | 2010 | 66 | 0.020 |
Why?
|
| Binding Sites | 2 | 2006 | 1371 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2010 | 65 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 544 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2009 | 14 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2009 | 22 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3476 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 210 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 316 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 178 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 203 | 0.020 |
Why?
|
| Aging | 1 | 1996 | 1302 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2008 | 59 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 251 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 461 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2010 | 370 | 0.020 |
Why?
|
| Lysosomes | 1 | 2009 | 262 | 0.020 |
Why?
|
| Models, Animal | 1 | 2009 | 483 | 0.020 |
Why?
|
| Biological Transport | 2 | 2000 | 370 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 454 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 99 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1911 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 688 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 708 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2006 | 86 | 0.020 |
Why?
|
| Sodium | 2 | 1998 | 307 | 0.020 |
Why?
|
| DNA | 2 | 2006 | 1675 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2009 | 525 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 671 | 0.020 |
Why?
|
| Serine | 1 | 2006 | 184 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 412 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2014 | 8592 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 991 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3423 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 2002 | 7 | 0.010 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2002 | 29 | 0.010 |
Why?
|
| Isoxazoles | 1 | 2002 | 24 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 60 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 163 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2002 | 276 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1533 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1125 | 0.010 |
Why?
|
| Receptor, Adenosine A3 | 1 | 2000 | 2 | 0.010 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2000 | 5 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1102 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 498 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4547 | 0.010 |
Why?
|
| Rubidium Radioisotopes | 1 | 2000 | 6 | 0.010 |
Why?
|
| Vanadates | 1 | 2000 | 12 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 194 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 89 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2000 | 33 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2000 | 100 | 0.010 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 1999 | 6 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2002 | 245 | 0.010 |
Why?
|
| Caspase 8 | 1 | 1999 | 24 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 1999 | 35 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 38 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 65 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 484 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 392 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2000 | 193 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 433 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 65 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 571 | 0.010 |
Why?
|
| Caspase 9 | 1 | 1999 | 76 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 289 | 0.010 |
Why?
|
| Plasmids | 1 | 2000 | 527 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1997 | 67 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1998 | 125 | 0.010 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 1997 | 23 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2000 | 235 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 54 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 371 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1997 | 400 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2000 | 285 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 98 | 0.010 |
Why?
|
| Captopril | 1 | 1996 | 27 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 270 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 913 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 633 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1334 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 2161 | 0.010 |
Why?
|
| Emphysema | 1 | 1994 | 68 | 0.010 |
Why?
|
| Swine | 1 | 1994 | 1216 | 0.010 |
Why?
|
| Neurons | 1 | 2000 | 2035 | 0.010 |
Why?
|